Gangwal Chemicals, located in Mumbai, India, is a premium distributor and specialist solutions provider occupying a leading position in the pharmaceutical industry with a focus on specialty excipients. The company is experiencing significant growth in the distribution of specialty ingredients in nutraceutical and cosmetic ingredients.
The acquisition is an important step in Barentz’s strategy to become one of the world’s leading distributors of active pharmaceutical and specialized nutraceutical ingredients. The acquisition is however subject to the usual closing conditions.
Planned Acquisition Strengthens Barentz’s Footprint in the High-Growth, Resilient Pharmaceutical Excipient Distribution Market and Increases Geographic Exposure in the Fast-Growing Asia-Pacific Region
Gangwal Founder Anil Jain will continue to lead the business after Barentz completes the acquisition
“We have long wanted to enter the Indian market,” said Hidde van der Wal, CEO of Barentz. “In Gangwal, we found the right partner because of the similarities in the way we do our business. We are extremely impressed with how the Gangwal team has developed the business and the long term relationships they have established with various global producers of excipients. This platform gives us a great leadership team and plenty of opportunities to create new business initiatives to support our global supplier network. We look forward to accelerating Gangwal’s future strategic growth.
“Over the past two years, we have witnessed a rapid consolidation of distributors in India,” added Jain, promoter and director of Gangwal Chemicals. “At Barentz, we found the ideal life science candidate to partner with. From a DNA and business perspective, we think and act the same. Together, we can find multiple synergies to strengthen our customer relationships with many new suppliers and products from Barentz’s life science ingredients portfolio.
